← Back to Search

Pharmacist Coordinated care Oncology Model (PCOM) for Comorbidity

N/A
Waitlist Available
Led By Karen Farris, PhD
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months following oaa initiation
Awards & highlights

Study Summary

This trial is to study if pharmacists working in oncology practices and those working in primary care practices can improve medication, symptom, and disease management of patients with hematological malignancies and multiple chronic conditions.

Eligible Conditions
  • Comorbidity
  • Leukemia
  • Chronic Lymphocytic Leukemia
  • Multiple Chronic Conditions

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months following oaa initiation
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months following oaa initiation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dose-adjusted proportion of days covered (PDC) for oral anti-cancer agent (OAA)
PDC for chronic condition medications
Secondary outcome measures
Percent of CMR notes that oncology pharmacist reviewed
Percent of CMRs where note was routed to oncology pharmacist
Percent of patients where oncology pharmacist reviewed PROM within 1 day of receiving scored PROM
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pharmacist Coordinated care Oncology Model (PCOM)Experimental Treatment3 Interventions
The Pharmacist Coordinated care Oncology Model includes patient self-reported symptoms and medication adherence, comprehensive medication review(s) and intentional communication between oncology and primary care pharmacists.

Find a Location

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
24,091 Total Patients Enrolled
AstraZenecaIndustry Sponsor
4,259 Previous Clinical Trials
288,593,896 Total Patients Enrolled
Karen Farris, PhDPrincipal InvestigatorUniversity of Michigan College of Pharmacy
1 Previous Clinical Trials
49 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
2021. "Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04595851.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top